Biotechnology

Filter

Current filters:

None

Popular Filters

1920 to 1944 of 2254 results

Epistem in fibrosis research deal with GlaxoSmithKline

13-03-2012

UK biotech and personalized medicines company Epistem (LSE:EHP) has entered into a three year biomarker…

BiotechnologyEpistemGlaxoSmithKlineLicensingPharmaceuticalResearch

NicOx earns $10M milestone under Bausch & Lomb accord

13-03-2012

French biotechnology firm NicOx (Euronext Paris: COX) will receive a $10 million milestone from US partner…

Bausch & LombBiotechnologyFinancialNicOxOphthalmicsPharmaceuticalResearch

Valeant on acquisition trail again

12-03-2012

In a third acquisition deal announced so far this year, Canada-based Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsPele Nova BiotecnologiaPharmaceuticalRegedermSouth AmericaValeant Pharmaceuticals

UCB and Domainex elaborate on cancer drug target collaboration

12-03-2012

Belgian drugmaker UCB (Euronext Brussels: UCB) and Domainex, a UK-based drug discovery company, have…

BiotechnologyDomainexOncologyPharmaceuticalResearchUCB

Anthera tanks as it halts Ph III heart drug trial

12-03-2012

US development-stage biophama company Anthera Pharmaceuticals (Nasdaq: ANTH) saw its shares plunge as…

Anthera PharmaceuticalsBiotechnologyCardio-vascularPharmaceuticalResearchvarespladib

ThromboGenics confident as it plans for ocriplasmin launch

12-03-2012

Belgian biopharma firm ThromboGenics (Euronext Brussels: THR) says that, over the past 12 months, it…

BiotechnologyFinancialocriplasminOphthalmicsRegulationResearchThromboGenics

Apexigen licenses MAb to Gansu Duyiwei for China

12-03-2012

Privately-held US biopharma firm Apexigen has entered into a collaboration to grant an exclusive license…

ApexigenAsia-PacificBiotechnologyGansu DuyiweiLicensingOncology

Canadian industry and government partner for health research and innovation

12-03-2012

Leading national health research and innovation organizations in Canada have come together to form Research…

BiotechnologyHealthcareNorth AmericaPharmaceuticalResearch

Biotech firms will increase R&D outsourcing and shift it overseas, finds Booz study

08-03-2012

As biopharmaceutical companies look to cut costs and improve speed-to-market, more of them plan to outsource…

BiotechnologyGlobalResearch

Mersana inks ADC deal with Endo Pharma

08-03-2012

Privately-held Mersana Therapeutics has joined the antibody-drug conjugate space, announcing its first…

BiotechnologyEndo PharmaceuticalsLicensingMersanaOncology

Gilead's Quad non-inferior to Atripla for HIV; Truvada objections

08-03-2012

US biotech firm Gilead Sciences (Nasdaq: GILD) yesterday announced full Phase III clinical trial results…

Anti-viralsAtriplaBiotechnologyGilead SciencesNorth AmericaQuadRegulationResearchTruvada

Aegerion files for lomitapide approval in USA and Europe

07-03-2012

Emerging US biotech firm Aegerion Pharmaceuticals (Nasdaq: AEGR) has submitted a New Drug Application…

Aegerion PharmaceuticalsBiotechnologyEuropelomitapideNorth AmericaRare diseasesRegulation

German biotech sector starts 2012 less optimistic

06-03-2012

Despite a more positive assessment of their current situation, German biotechnology companies are starting…

BiotechnologyEuropeFinancialResearch

Agenus expands deal with GlaxoSmithKline; Nuron in-licenses vaccines

06-03-2012

US biotech firm Agenus (Nasdaq: AGEN) says it has amended the QS-21 license and manufacturing agreement…

AgenusAkshaya BioBiotechnologyGlaxoSmithKlineLicensingNuron BiotechPharmaceuticalVaccines

EMA updates market authorization holder requirements

05-03-2012

Pharmaceutical regulator the European Medicines Agency said yesterday that it has published an updated…

BiotechnologyEuropePharmaceuticalRegulation

Bargaining power boost for YM BioSciences

05-03-2012

The share offering last week by Canadian firm biotechnology firm YM BioSciences (TSX: YM), which raised…

BiotechnologyFinancialOncologyResearchYM Biosciences

Amgen says tender offer for Micromet on track

04-03-2012

Global biotech leader Amgen (Nasdaq: AMGN) says that all conditions to the closing of the tender offer…

AmgenBiotechnologyMergers & AcquisitionsMicromet

IFPMA tightens Code of Practice for health interactions

02-03-2012

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice…

BiotechnologyGlobalMarkets & MarketingPharmaceutical

Galapagos leaps on $1.35 billion RA drug deal with Abbott Labs

01-03-2012

Belgian drug developer Galapagos (Euronext: GLPG) saw its shares rocket 27% to a record high 13.89 euros…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyGalapagosLicensingPharmaceutical

Biogen Idec files oral MS candidate in USA

01-03-2012

US biotech firm Biogen Idec (Nadaq: BIIB) has submitted its orally-active drug for relapsing-remitting…

Biogen IdecBiotechnologyNeurologicalRegulation

Genzyme to start shipping Fabrazyme from newly-approved plant

01-03-2012

French drug major Sanofi's (Euronext: SAN) US subsidiary Genzyme says that it has begun shipping its…

BiotechnologyFabrazymeGenzymeMarkets & MarketingPharmaceuticalRare diseasesSanofi

Shire buys rights to arGEN-X technology for rare diseases

01-03-2012

Dutch/Belgian preclinical stage biotech company arGEN-X, focused on the discovery and development of…

BiotechnologyLicensingPharmaceuticalRare diseases

Dompe to acquire 100% control of Anabasis

01-03-2012

Italian biopharmaceutical firm Dompe has entered into a definitive agreement to acquire 100% of Anabasis…

BiotechnologyMergers & AcquisitionsOphthalmics

1920 to 1944 of 2254 results

Back to top